NUTRIGENOMICS TESTING SERVICE BUSINESS PLAN

I. Executive Summary

Company Description

The company name is not provided. We are a U.S.-based health technology company launching in 2026 that operates in the personalized nutrition and nutrigenomics sector. Our core offering combines at-home DNA testing with a curated e-commerce marketplace to deliver actionable nutrition plans and recommended products directly to consumers. We operate from a centralized office with a $6,500 monthly lease and a team of geneticists, dietitians, and software engineers who translate complex genetic data into clear, daily nutrition guidance. One-liner: We turn DNA insights into daily meals and supplements delivered to your door.

Our main activities are genetic testing, algorithmic interpretation, personalized plan creation, product curation, and direct-to-consumer fulfillment. What sets us apart is the end-to-end blend of clinical expertise and an owned commerce channel that closes the loop from insight to implementation. Target customers are health-conscious U.S. adults seeking data-driven nutrition and convenient delivery. Short-term goals: launch in 2026 and validate product-market fit. Long-term goals: scale customer acquisition, expand product assortment, and lead the shift toward mainstream data-driven health. One-liner: We make biologic insights easy to act on, not just read about.

Problem

Generic nutrition and supplement programs ignore individual genetic differences—cited as affecting up to 99.9% of genomic variance—so most U.S. adults receive one-size-fits-all advice that often fails to produce durable weight or health improvements.

Consumers spend billions annually on diets, supplements, and programs that don't map to metabolic markers. They lose money, fail to sustain outcomes, struggle to interpret genetic and lab data, face decision paralysis on food and supplement choices, and accumulate long-term health risk from misaligned nutrition. There is no widely adopted service that links genetic predisposition to daily caloric and micronutrient targets in a simple, actionable way.

Solution

Many U.S. consumers waste time and money on one-size-fits-all diets that ignore genetic differences, and the market separates diagnostic data from the products people need. Our at-home, non-invasive DNA collection kit analyzes genetic markers tied to metabolism and food intolerances and converts raw data into a hyper-personalized nutrition report written for the average consumer. One sentence: we turn genetic insight into clear, usable nutrition guidance.

We pair the report with a direct-to-consumer e-commerce platform that curates vetted third-party brands and delivers tailored supplement packs to the user’s door, closing the gap between data and daily habit; target launch is 2026. One sentence: we link test-to-table so consumers get actionable products, not just complex data.

Mission Statement

Our mission is to unlock the power of personal biology to help every individual achieve optimal health through hyper-personalized nutrition, turning genetic and lifestyle data into clear, daily food choices. We commit to making data-driven wellness accessible, actionable, and private, upholding scientific integrity and strong data security for our community. We exist to end the frustration of one-size-fits-all diets and lead the transition to a world of precision nutrition.

Key Success Factors

These are the core elements that will drive revenue, trust, and margin for the nutrigenomics testing service.

• Proprietary algorithm that provides the scientific foundation for personalized recommendations.
• 40% repeat customer rate by 2030 sustaining long-term profitability and lifetime value.
• Partnerships with CLIA/CAP-certified labs and vetted supplement brands ensuring product quality.
• Marketing efficiency with CAC of $85 today, targeted to fall to $55 in five years.
• Clinical team led by a Lead Geneticist and Registered Dietitians maintaining trust and clinical rigor.

Financial Summary

Brief financial snapshot for the Executive Summary of the Nutrigenomics Testing Service business plan.

The business requires $585,000 in initial capital expenditures to build the scalable technology platform; break-even is forecast for Jan‑2027, payback is 21 months, with an overall IRR of 12.27% and ROE of 141.13%.

Financials show fast scale from $1.48M in Year 1 to $111.46M by Year 5, with strong profitability by Year 2.

Funding Requirements

The plan requires $1,399,000 to fund product development, cover Year‑1 operating losses, execute a 2026 go‑to‑market campaign, and maintain minimum cash until break‑even in Jan‑2027 while targeting a 21‑month payback and a projected IRR of 12.27%.